Monday Pre-Market Top Gainers $TLGT $SYBX $SCKT $VERU

SYBX [NASD]

60% 80mc 28f

Dec-14-20 06:00AM	Synlogic Announces Advancement of SYNB1891 to Combination Arm Dosing with PD-L1 Checkpoint Inhibitor in the on-going Phase 1 Study for the Treatment of Solid Tumors and Lymphoma PR Newswire
Dec-09-20 06:30AM	Synlogic Appoints Michael Heffernan to its Board of Directors PR Newswire
Dec-07-20 12:27PM	Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering PR Newswire
Dec-02-20 10:47PM	Is Synlogic (SYBX) A Good Stock To Buy Now? Insider Monkey +6.9

VERU [NASD]

80% 120mc 52f

Dec-14-20 07:30AM	Veru Reports Positive Phase 2 Clinical Trial Results for Enobosarm, Selective Androgen Receptor Targeting Agent, for Endocrine Resistant Metastatic Breast Cancer GlobeNewswire
07:00AM	VERU-111, Cytoskeleton Disruptor, Demonstrates Efficacy in Preclinical Models of Human Triple Negative Breast Cancer GlobeNewswire

ANPC [NASD]

120% 50mc 1f

Dec-14-20 07:30AM	AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases GlobeNewswire
Dec-10-20 11:01PM	News Flash: Analysts Just Made An Incredible Upgrade To Their AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Forecasts Simply Wall St.

ARVN [NASD]

130% 1.2Bmc 35f

Dec-14-20 07:00AM	Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110 GlobeNewswire
Dec-11-20 04:15PM	Arvinas to Host Webcast Presentation of New Clinical Data from ARV-471 and ARV-110 PROTAC® Protein Degrader Development Programs GlobeNewswire

Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save